Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01864369
Other study ID # MOP 126118
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2013
Est. completion date July 2018

Study information

Verified date June 2021
Source University Health Network, Toronto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic Heart Failure (CHF) is a growing public health issue in Canada. Hospital re-admission within 1-year after diagnosis is 25-40%, and the 5-year rate of CHF death is 50%. Counseling by multidisciplinary health care teams helps CHF patients to improve self-care behaviors (for medications, diet, exercise, smoking cessation and symptom monitoring), and this reduces the rate of death and CHF hospitalization. In the absence of intervention, patient adherence to these behaviors is below recommended standards and quality of life among CHF patients becomes progressively compromised. A major challenge is to make self-care counseling available without overtaxing health care resources. This year multicenter clinical trial will establish and evaluate a Canadian e-platform that provides multidisciplinary e-counseling to help patients with CHF to initiate and maintain recommended self-care behaviors. The investigators will recruit 298 CHF patients in Toronto, Montreal and Vancouver. The investigators hypothesize that a 12-month program of e-Counseling + Usual Care versus general eInfo + Usual Care will improve quality of life, self-care behaviors, program engagement, and heart health. This proposal is based upon previous clinical trials in CHF, e-health and preventive lifestyle counseling by our team. The novel contribution of this research is that it will establish an infrastructure for a pan-Canadian e-platform in preventive e-counseling for CHF. A key feature of this proposal is that our multidisciplinary team will work with professional heart health organizations to share our findings and e-health resources with the public and other health care professionals in Canada, which will help to galvanize research and clinical work in eCounseling. Our clinical trial will strengthen eCounseling services in order to improve the quality of life of patients with CHF.


Recruitment information / eligibility

Status Completed
Enrollment 248
Est. completion date July 2018
Est. primary completion date January 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Male and female patients 18 years of age who are diagnosed with heart failure with reduced ejection fraction ("systolic HF") corresponding to New York Heart Association Class II-III for 3 months prior to enrolment; 2. documentation of LVEF 40%; 3. subject has access to a personal computer; Exclusion Criteria: 1. Documentation at enrolment of renal failure, significant liver disease or poorly controlled diabetes mellitus; 2. persistent systolic or diastolic hypertension [systolic > 170 mmHg or diastolic > 100 mmHg despite antihypertensive therapy; 3. CHF secondary to cardiovascular co-morbidities/procedures; 4. previous heart transplant or wait listed for heart transplant at time of enrolment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
eCounseling + Usual Care
This intervention will use film vignettes and interactive web pages. The e-counseling messages will promote: (i) validation of the subject's stage of "readiness" for behavior change, (ii) collaborative participation by means of subject-selected menus, (iii) reinforcement of "change talk" to resolve ambivalence, (iv) use of self-help information and e-tools for self-monitoring of targeted self-care behaviors, and (v) development of cognitive-behavioral skills to build and strengthen efficacy. Messages will be proactively sent to Controls according to the following schedule: weekly for months 1 to 4, bi-weekly for months 5 to 8, and monthly for months 9 to 12.

Locations

Country Name City State
Canada Montreal Heart Institute Montreal Quebec
Canada University Health Network Toronto Ontario
Canada St.Paul's Hospital- UBC Vancouver British Columbia

Sponsors (2)

Lead Sponsor Collaborator
University Health Network, Toronto Heart and Stroke Foundation of Ontario

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of Life: Kansas City Cardiomyopathy Questionnaire The primary outcome in CHF-CePPORT is quality of life, as measured by the number of subjects who demonstrate a clinically meaningful increase of =5 points on the summary index of the Kansas City Cardiomyopathy Questionnaire (KCCQ). 12 months
Secondary Program engagement and usability Active engagement with digital platform: total time, # logons, % material accessed 4- and 12- months
Secondary Behavioral,functional and clinical outcomes Quality of life: number of subjects with KCCQ =5 points 4- and 12- months
Secondary Behavioral, clinical and funcitonal outcomes Adherence to daily dietary guidelines for fruit and vegetable intake: NIH/NCI Diet History Questionnaire. 4 and 12- months
Secondary Behavioral, functional and clinical outcomes Physical activity: 4-day step count with Triaxial Accelerometer. 4- and 12- months
Secondary Behavioral, functional and clinical outcomes Self-reported daily activity: The Physical Activity Scale for the Elderly. 4- and 12- months
Secondary Behavioral, functional and clinical outcomes Psychological adjustment: Patient Health Questionnaire - 9-item scale (Depression) 4- and 12- months
Secondary Clinical and functional assesments. Functional capacity: 6-minute walk test. 12-months
Secondary Behavioral, functional and clinical outcomes Patient Health Questionnaire: PHQ-9 (Depression) and GAD-7 (Anxiety) 4- and 12- months
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy

External Links